Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 579

1.

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.

Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Siskind D, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A.

Schizophr Res. 2019 Jan 28. pii: S0920-9964(19)30029-5. doi: 10.1016/j.schres.2019.01.021. [Epub ahead of print]

PMID:
30704862
2.

Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance.

Wagner E, Löhrs L, Siskind D, Honer WG, Falkai P, Hasan A.

J Psychopharmacol. 2019 Jan 30:269881118822171. doi: 10.1177/0269881118822171. [Epub ahead of print]

PMID:
30696332
3.

Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality.

Schmitt A, Maurus I, Rossner MJ, Röh A, Lembeck M, von Wilmsdorff M, Takahashi S, Rauchmann B, Keeser D, Hasan A, Malchow B, Falkai P.

Front Psychiatry. 2018 Dec 21;9:690. doi: 10.3389/fpsyt.2018.00690. eCollection 2018. Review.

4.

The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.

Anderson-Schmidt H, Gade K, Malzahn D, Papiol S, Budde M, Heilbronner U, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Comes AL, Flatau L, Gryaznova A, Hake M, Reitt M, Schmauß M, Juckel G, Reimer J, Zimmermann J, Figge C, Reininghaus E, Anghelescu IG, Konrad C, Thiel A, von Hagen M, Koller M, Stierl S, Scherk H, Spitzer C, Folkerts H, Becker T, Dietrich DE, Andlauer TFM, Degenhardt F, Nöthen MM, Witt SH, Rietschel M, Wiltfang J, Falkai P, Schulze TG.

Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30721-7. doi: 10.1016/j.schres.2018.12.025. [Epub ahead of print]

PMID:
30611655
5.

Predicting instructed simulation and dissimulation when screening for depressive symptoms.

Goerigk S, Hilbert S, Jobst A, Falkai P, Bühner M, Stachl C, Bischl B, Coors S, Ehring T, Padberg F, Sarubin N.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec 12. doi: 10.1007/s00406-018-0967-2. [Epub ahead of print]

PMID:
30542818
6.

Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.

Kirchner SK, Ozkan S, Musil R, Spellmann I, Kannayian N, Falkai P, Rossner M, Papiol S.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec 7. doi: 10.1007/s00406-018-0961-8. [Epub ahead of print]

PMID:
30523404
7.

Prospective acceptance of distinct mobile mental health features in psychiatric patients and mental health professionals.

Hendrikoff L, Kambeitz-Ilankovic L, Pryss R, Senner F, Falkai P, Pogarell O, Hasan A, Peters H.

J Psychiatr Res. 2019 Feb;109:126-132. doi: 10.1016/j.jpsychires.2018.11.025. Epub 2018 Dec 1.

PMID:
30530207
8.

Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.

Kambeitz-Ilankovic L, Haas SS, Meisenzahl E, Dwyer DB, Weiske J, Peters H, Möller HJ, Falkai P, Koutsouleris N.

Neuroimage Clin. 2018 Dec 3. pii: S2213-1582(18)30372-3. doi: 10.1016/j.nicl.2018.101624. [Epub ahead of print]

9.

WFSBP guidelines on how to grade treatment evidence for clinical guideline development.

Hasan A, Bandelow B, Yatham LN, Berk M, Falkai P, Möller HJ, Kasper S; WFSBP Guideline Task Force Chairs.

World J Biol Psychiatry. 2019 Jan;20(1):2-16. doi: 10.1080/15622975.2018.1557346. Epub 2019 Feb 4.

PMID:
30526182
10.

Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder.

Budde M, Friedrichs S, Alliey-Rodriguez N, Ament S, Badner JA, Berrettini WH, Bloss CS, Byerley W, Cichon S, Comes AL, Coryell W, Craig DW, Degenhardt F, Edenberg HJ, Foroud T, Forstner AJ, Frank J, Gershon ES, Goes FS, Greenwood TA, Guo Y, Hipolito M, Hood L, Keating BJ, Koller DL, Lawson WB, Liu C, Mahon PB, McInnis MG, McMahon FJ, Meier SM, Mühleisen TW, Murray SS, Nievergelt CM, Nurnberger JI Jr, Nwulia EA, Potash JB, Quarless D, Rice J, Roach JC, Scheftner WA, Schork NJ, Shekhtman T, Shilling PD, Smith EN, Streit F, Strohmaier J, Szelinger S, Treutlein J, Witt SH, Zandi PP, Zhang P, Zöllner S, Bickeböller H, Falkai PG, Kelsoe JR, Nöthen MM, Rietschel M, Schulze TG, Malzahn D.

Eur Neuropsychopharmacol. 2019 Jan;29(1):156-170. doi: 10.1016/j.euroneuro.2018.10.005. Epub 2018 Nov 29.

11.

Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study.

Hooshmand B, Rusanen M, Ngandu T, Leiviskä J, Sindi S, von Arnim CAF, Falkai P, Soininen H, Tuomilehto J, Kivipelto M.

Am J Med. 2018 Nov 29. pii: S0002-9343(18)31136-7. doi: 10.1016/j.amjmed.2018.11.013. [Epub ahead of print]

PMID:
30502316
12.

Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment.

Steiner J, Prüss H, Köhler S, Frodl T, Hasan A, Falkai P.

World J Biol Psychiatry. 2018 Dec 4:1-14. doi: 10.1080/15622975.2018.1555376. [Epub ahead of print]

PMID:
30513253
13.

Self-esteem fully mediates positive life events and depressive symptoms in a sample of 173 patients with affective disorders.

Sarubin N, Goerigk S, Padberg F, Übleis A, Jobst A, Erfurt L, Schumann C, Nadjiri A, Dewald-Kaufmann J, Falkai P, Bühner M, Naumann F, Hilbert S.

Psychol Psychother. 2018 Nov 28. doi: 10.1111/papt.12205. [Epub ahead of print]

PMID:
30488539
14.

Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems.

Raabe FJ, Galinski S, Papiol S, Falkai PG, Schmitt A, Rossner MJ.

NPJ Schizophr. 2018 Nov 19;4(1):23. doi: 10.1038/s41537-018-0066-4. Review.

15.

Impaired recovery in affective disorders and schizophrenia: sharing a common pathophysiology?

Falkai P, Schmitt A, Koutsouleris N.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):739-740. doi: 10.1007/s00406-018-0951-x. No abstract available.

PMID:
30374704
16.

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.

Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S, Rosen M, Ruef A, Dwyer DB, Paolini M, Chisholm K, Kambeitz J, Haidl T, Schmidt A, Gillam J, Schultze-Lutter F, Falkai P, Reiser M, Riecher-Rössler A, Upthegrove R, Hietala J, Salokangas RKR, Pantelis C, Meisenzahl E, Wood SJ, Beque D, Brambilla P, Borgwardt S; PRONIA Consortium.

JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172. doi: 10.1001/jamapsychiatry.2018.2165.

PMID:
30267047
17.

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH).

Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, Brand S, Cordes J, Malchow B, Gerber M, Schmitt A, Correll CU, De Hert M, Gaughran F, Schneider F, Kinnafick F, Falkai P, Möller HJ, Kahl KG.

Eur Psychiatry. 2018 Oct;54:124-144. doi: 10.1016/j.eurpsy.2018.07.004.

PMID:
30257806
18.

Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.

Kamp D, Engelke C, Wobrock T, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Raees A, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A, Cordes J.

Schizophr Res. 2018 Sep 21. pii: S0920-9964(18)30575-9. doi: 10.1016/j.schres.2018.09.017. [Epub ahead of print] No abstract available.

PMID:
30249471
19.

Verhaltensauffälliger Patient: was tun?

Falkai P.

MMW Fortschr Med. 2018 Sep;160(15):44. doi: 10.1007/s15006-018-0884-3. Review. German. No abstract available.

PMID:
30206850
20.

[The crying patient].

Winter J, Falkai P, Schüle C.

MMW Fortschr Med. 2018 Sep;160(15):50-53. doi: 10.1007/s15006-018-0887-0. Review. German. No abstract available.

PMID:
30206847
21.

[The speechless patient].

Häckert J, Falkai P, Perneczky R, Pogarell O.

MMW Fortschr Med. 2018 Sep;160(15):53-56. doi: 10.1007/s15006-018-0888-z. Review. German. No abstract available.

PMID:
30206846
22.

Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.

Kamp F, Proebstl L, Penzel N, Adorjan K, Ilankovic A, Pogarell O, Koller G, Soyka M, Falkai P, Koutsouleris N, Kambeitz J.

Neuropsychopharmacology. 2019 Mar;44(4):660-667. doi: 10.1038/s41386-018-0191-9. Epub 2018 Aug 27. Review.

PMID:
30188512
23.

A longitudinal approach to biological psychiatric research: The PsyCourse study.

Budde M, Anderson-Schmidt H, Gade K, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Papiol S, Andlauer TFM, Comes AL, Schulte EC, Klöhn-Saghatolislam F, Gryaznova A, Hake M, Bartholdi K, Flatau L, Reitt M, Quast S, Stegmaier S, Meyers M, Emons B, Haußleiter IS, Juckel G, Nieratschker V, Dannlowski U, Schaupp SK, Schmauß M, Zimmermann J, Reimer J, Schulz S, Wiltfang J, Reininghaus E, Anghelescu IG, Arolt V, Baune BT, Konrad C, Thiel A, Fallgatter AJ, Figge C, von Hagen M, Koller M, Lang FU, Wigand ME, Becker T, Jäger M, Dietrich DE, Stierl S, Scherk H, Spitzer C, Folkerts H, Witt SH, Degenhardt F, Forstner AJ, Rietschel M, Nöthen MM, Falkai P, Schulze TG, Heilbronner U.

Am J Med Genet B Neuropsychiatr Genet. 2018 Aug 2. doi: 10.1002/ajmg.b.32639. [Epub ahead of print]

PMID:
30070057
24.

Effects of Three Months of Aerobic Endurance Training on Motor Cortical Excitability in Schizophrenia Patients and Healthy Subjects.

Roeh, Malchow B, Levold K, Labusga M, Keller-Varady K, Schneider-Axmann T, Wobrock T, Schmitt A, Falkai P, Hasan A.

Neuropsychobiology. 2018 Jul 12:1-8. doi: 10.1159/000489714. [Epub ahead of print]

PMID:
30001538
25.

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM.

Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A.

Br J Psychiatry. 2018 Sep;213(3):561. doi: 10.1192/bjp.2018.77. Epub 2018 Jul 10.

PMID:
29986772
26.

Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.

Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M, Anderson-Schmidt H, Andlauer TF, Anghelescu IG, Ardau R, Arias B, Arolt V, Aubry JM, Backlund L, Bartholdi K, Bauer M, Baune BT, Becker T, Bellivier F, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Budde M, Cervantes P, Chillotti C, Cichon S, Clark SR, Colom F, Comes AL, Cruceanu C, Czerski PM, Dannlowski U, Dayer A, Del Zompo M, DePaulo JR, Dietrich DE, Étain B, Ethofer T, Falkai P, Fallgatter A, Figge C, Flatau L, Folkerts H, Frisen L, Frye MA, Fullerton JM, Gade K, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Gryaznova A, Hake M, Hauser J, Herms S, Hoffmann P, Hou L, Jäger M, Jamain S, Jiménez E, Juckel G, Kahn JP, Kassem L, Kelsoe J, Kittel-Schneider S, Kliwicki S, Klohn-Sagatholislam F, Koller M, König B, Konrad C, Lackner N, Laje G, Landén M, Lang FU, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, McMahon FJ, Mitchell PB, Mitjans M, Mondimore FM, Monteleone P, Nieratschker V, Nievergelt CM, Novák T, Ösby U, Pfennig A, Potash JB, Reich-Erkelenz D, Reif A, Reimer J, Reininghaus E, Reitt M, Ripke S, Rouleau GA, Rybakowski JK, Schalling M, Scherk H, Schmauß M, Schofield PR, Schubert KO, Schulte EC, Schulz S, Senner F, Severino G, Shekhtman T, Shilling PD, Simhandl C, Slaney CM, Spitzer C, Squassina A, Stamm T, Stegmaier S, Stierl S, Stopkova P, Thiel A, Tighe SK, Tortorella A, Turecki G, Vieta E, Veeh J, von Hagen M, Wigand ME, Wiltfang J, Witt S, Wright A, Zandi PP, Zimmermann J, Nöthen M, Rietschel M, Schulze TG.

Bipolar Disord. 2018 Jun 28. doi: 10.1111/bdi.12659. [Epub ahead of print]

PMID:
29956436
27.

Improving working memory in schizophrenia: Effects of 1 mA and 2 mA transcranial direct current stimulation to the left DLPFC.

Papazova I, Strube W, Becker B, Henning B, Schwippel T, Fallgatter AJ, Padberg F, Palm U, Falkai P, Plewnia C, Hasan A.

Schizophr Res. 2018 Dec;202:203-209. doi: 10.1016/j.schres.2018.06.032. Epub 2018 Jun 25.

PMID:
29954701
28.

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093/ijnp/pyy048.

29.

Psychiatry and psychiatrists: Fourteen core statements.

Galderisi S, Falkai P.

Eur Psychiatry. 2018 Aug;52:136-138. doi: 10.1016/j.eurpsy.2018.05.013. No abstract available.

PMID:
29914673
30.

Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.

Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Marie-Claire C, Cervantes P, Chen GB, Chen HC, Chillotti C, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dayer A, Étain B, Falkai P, Frisén L, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, López Jaramillo CA, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm TJ, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt SH, Wright AJ, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus E, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, McMahon FJ, Schulze TG, Rietschel M, Nöthen MM, Cichon S.

Front Psychiatry. 2018 May 31;9:207. doi: 10.3389/fpsyt.2018.00207. eCollection 2018.

31.

The Role of Self-Esteem in Depression: A Longitudinal Study.

Hilbert S, Goerigk S, Padberg F, Nadjiri A, Übleis A, Jobst A, Dewald-Kaufmann J, Falkai P, Bühner M, Naumann F, Sarubin N.

Behav Cogn Psychother. 2019 Mar;47(2):244-250. doi: 10.1017/S1352465818000243. Epub 2018 Apr 25.

PMID:
29692278
32.

[Web-based field studies on diagnostic classification and code assignment of mental disorders: comparison of ICD-11 and ICD-10].

Gaebel W, Riesbeck M, Zielasek J, Kerst A, Meisenzahl-Lechner E, Köllner V, Rose M, Hofmann T, Schäfer I, Lotzin A, Briken P, Klein V, Brunner F, Keeley JW, Rebello TJ, Andrews HF, Reed GM, Kostanjsek NFI, Hasan A, Russek P, Falkai P.

Fortschr Neurol Psychiatr. 2018 Mar;86(3):163-171. doi: 10.1055/s-0044-100508. Epub 2018 Apr 5. Review. German.

PMID:
29621822
33.

[Beginning of a new series: psychiatry and neurology based issues].

Falkai P, Gaebel W.

Fortschr Neurol Psychiatr. 2018 Mar;86(3):147-148. doi: 10.1055/s-0044-102309. Epub 2018 Apr 5. German. No abstract available.

PMID:
29621816
34.

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders.

Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A.

Br J Psychiatry. 2018 May;212(5):318-320. doi: 10.1192/bjp.2018.24. Epub 2018 Mar 28.

PMID:
29587895
35.

Reply to: Sample Size, Model Robustness, and Classification Accuracy in Diagnostic Multivariate Neuroimaging Analyses.

Kambeitz J, Cabral C, Sacchet MD, Gotlib IH, Zahn R, Serpa MH, Walter M, Falkai P, Koutsouleris N.

Biol Psychiatry. 2018 Dec 1;84(11):e83-e84. doi: 10.1016/j.biopsych.2018.01.023. Epub 2018 Feb 7. No abstract available.

PMID:
29580572
36.

[An effective treatment concept for patients with substance use disorders].

Adorjan K, Thoma C, Tchipeva E, Janjic K, Leidger A, Hoch E, Koller G, Falkai P, Pogarell O, Karch S.

MMW Fortschr Med. 2017 Oct;159(Suppl 6):1-5. doi: 10.1007/s15006-017-0079-3. Epub 2017 Oct 5. German.

PMID:
29557094
37.

Brain Subtyping Enhances The Neuroanatomical Discrimination of Schizophrenia.

Dwyer DB, Cabral C, Kambeitz-Ilankovic L, Sanfelici R, Kambeitz J, Calhoun V, Falkai P, Pantelis C, Meisenzahl E, Koutsouleris N.

Schizophr Bull. 2018 Aug 20;44(5):1060-1069. doi: 10.1093/schbul/sby008.

PMID:
29529270
38.

[Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach].

Steiner J, Prüß H, Köhler S, Hasan A, Falkai P.

Nervenarzt. 2018 May;89(5):530-538. doi: 10.1007/s00115-018-0499-z. Review. German.

PMID:
29523913
39.

Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age.

Ramos-Miguel A, Jones AA, Sawada K, Barr AM, Bayer TA, Falkai P, Leurgans SE, Schneider JA, Bennett DA, Honer WG.

Neurobiol Dis. 2018 Jun;114:31-44. doi: 10.1016/j.nbd.2018.02.006. Epub 2018 Feb 26.

PMID:
29496544
40.

Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.

Hansbauer M, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A.

Psychiatry Res. 2018 May;263:22-29. doi: 10.1016/j.psychres.2018.02.030. Epub 2018 Feb 17.

PMID:
29482042
41.

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.

Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Teipel S, Kilimann I, Ramirez A, Rossor M, Jucker M, Chhatwal J, Spottke A, Boecker H, Brosseron F, Falkai P, Fliessbach K, Heneka MT, Laske C, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Kofler B, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Weiner M, Lee JH, Salloway S, Danek A, Goate A, Schofield PR, Bateman RJ, Ewers M.

Brain. 2018 Apr 1;141(4):1186-1200. doi: 10.1093/brain/awy008.

42.

Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats.

von Wilmsdorff M, Manthey F, Bouvier ML, Staehlin O, Falkai P, Meisenzahl-Lechner E, Schmitt A, Gebicke-Haerter PJ.

Eur Arch Psychiatry Clin Neurosci. 2018 Sep;268(6):555-563. doi: 10.1007/s00406-018-0872-8. Epub 2018 Feb 5.

PMID:
29404686
43.

Machine Learning Approaches for Clinical Psychology and Psychiatry.

Dwyer DB, Falkai P, Koutsouleris N.

Annu Rev Clin Psychol. 2018 May 7;14:91-118. doi: 10.1146/annurev-clinpsy-032816-045037. Epub 2018 Jan 29.

PMID:
29401044
44.

Effects of exercise-based interventions in severe mental illness: a feasibility study.

Ogunyankin F, Nichols H, Park S, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2018 Jan 19. doi: 10.1007/s00406-018-0864-8. [Epub ahead of print] No abstract available.

PMID:
29350265
45.

[Pioneering research developments in psychiatry].

Falkai P.

Fortschr Neurol Psychiatr. 2018 Jan;86(1):16-17. doi: 10.1055/s-0043-124288. Epub 2018 Jan 17. German. No abstract available.

PMID:
29342481
46.

Commentary on "Systems Neuroscience of Psychosis (SyNoPsis): Mapping Schizophrenia Symptoms onto Brain Systems".

Falkai P.

Neuropsychobiology. 2017;75(3):122-123. doi: 10.1159/000485219. Epub 2017 Dec 19. No abstract available.

PMID:
29258118
47.

Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.

International Consortium on Lithium Genetics (ConLi+Gen), Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, Arias B, Aubry JM, Backlund L, Bhattacharjee AK, Bellivier F, Benabarre A, Bengesser S, Biernacka JM, Birner A, Brichant-Petitjean C, Cervantes P, Chen HC, Chillotti C, Cichon S, Cruceanu C, Czerski PM, Dalkner N, Dayer A, Del Zompo M, DePaulo JR, Étain B, Falkai P, Forstner AJ, Frisen L, Frye MA, Fullerton JM, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Grof P, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kuo PH, Kato T, Kelsoe J, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Tortorella A, Manchia M, Martinsson L, McCarthy MJ, McElroy S, Colom F, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Novák T, O'Donovan C, Ozaki N, Ösby U, Pfennig A, Potash JB, Reif A, Reininghaus E, Rouleau GA, Rybakowski JK, Schalling M, Schofield PR, Schweizer BW, Severino G, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Squassina A, Stamm T, Stopkova P, Maj M, Turecki G, Vieta E, Volkert J, Witt S, Wright A, Zandi PP, Mitchell PB, Bauer M, Alda M, Rietschel M, McMahon FJ, Schulze TG, Baune BT.

JAMA Psychiatry. 2018 Jan 1;75(1):65-74. doi: 10.1001/jamapsychiatry.2017.3433.

48.

Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression.

Jobst A, Sabaß L, Hall D, Brücklmeier B, Buchheim A, Hall J, Sarubin N, Zill P, Falkai P, Brakemeier EL, Padberg F.

J Affect Disord. 2018 Feb;227:206-213. doi: 10.1016/j.jad.2017.10.037. Epub 2017 Oct 24.

PMID:
29100154
49.

On the search of new treatment strategies in patients with affective disorders.

Schmitt A, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):709-710. doi: 10.1007/s00406-017-0844-4. No abstract available.

PMID:
29071371
50.

Bedeutung psychischer Erkrankungen für das Gesundheitssystem in Deutschland.

Falkai P.

Drug Res (Stuttg). 2017 Nov;67(S 01):S3-S4. doi: 10.1055/s-0043-116525. Epub 2017 Oct 25. German. No abstract available.

Supplemental Content

Loading ...
Support Center